Suppr超能文献

肌张力障碍——临床、神经病理学及治疗综述

Dystonia--a clinical, neuropathological and therapeutic review.

作者信息

Wissel J, Poewe W

机构信息

Abteilung für Neurologie, Universitätsklinik Rudolf Virchow, Freie Universität Berlin, Federal Republic of Germany.

出版信息

J Neural Transm Suppl. 1992;38:91-104.

PMID:1491251
Abstract

Dystonia is a syndrome characterized by sustained muscle contractions frequently causing twisting and repetitive movements or abnormal posture. For diagnosis, prognosis and therapy, it is useful to classify dystonia with regard to types of abnormal movements present, their mode of activation and topographical distribution taking into account age of onset, and etiology. The majority of cases are idiopathic, or primary dystonias, while in a minority environmental, structural, or metabolic causes can be identified. Primary dystonias can be familial or sporadic. The most important neurophysiological phenomenon in dystonia is pathological cocontraction of antagonistic muscles, while there is no consistent neuropathological abnormality in idiopathic dystonia. Causal therapies for dystonia are only possible in a few symptomatic forms (M. Wilson, Segawa-syndrome). As a rule, treatment has to be symptomatic but results of systemic pharmacotherapies remain disappointing. For adult onset focal dystonias, a breakthrough in symptomatic therapy has been achieved with local "chemical" denervation by means of botulinum toxin type A injections.

摘要

肌张力障碍是一种以持续性肌肉收缩为特征的综合征,常导致扭曲和重复性动作或异常姿势。为了进行诊断、预后评估和治疗,根据存在的异常运动类型、其激活方式和地形分布,并考虑发病年龄和病因,对肌张力障碍进行分类是有用的。大多数病例是特发性的,即原发性肌张力障碍,而少数病例可确定为环境、结构或代谢原因。原发性肌张力障碍可以是家族性的或散发性的。肌张力障碍最重要的神经生理现象是拮抗肌的病理性共同收缩,而特发性肌张力障碍没有一致的神经病理异常。肌张力障碍的病因治疗仅适用于少数症状性类型(威尔逊氏病、Segawa综合征)。通常,治疗必须是对症性的,但全身药物治疗的结果仍然令人失望。对于成人起病的局灶性肌张力障碍,通过注射A型肉毒杆菌毒素进行局部“化学”去神经支配,在对症治疗方面取得了突破。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验